ADO 0.00% 2.1¢ anteotech ltd

Ann: European RAT Clinical Trial Halted to Refocus Initiatives, page-49

  1. 750 Posts.
    lightbulb Created with Sketch. 89
    look I definitely agree that it’s a good decision, but the setback on income is immense in my opinion.

    unless as I mentioned, the potential was never there due to issues that were kept in the dark.

    either way the only positive to come out of this is a ceo who can make quick decisions.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.